Risk of relapse for chronic myeloid leukemia patients may be reduced through drug combination after discontinuing initial therapy, according to a Northwestern Medicine study published in the journal Leukemia.
Elagolix, a newly developed orally administered drug, was effective in reducing heavy menstrual bleeding in women with uterine fibroids, according to a recent Northwestern Medicine clinical trial.
These images illustrate the physical reality Northwestern scientists work within, striving to uncover the mysteries of biology, chemistry and medicine.
Deaths related to choking on objects in children and adolescents — especially among children younger than three years old — have decline steadily for 50 years, according to a study published in JAMA.
Mike Boctor, a first-year student, combined his passions for film and medicine by directing an award-winning short film about the healing process for survivors of sexual assault.
Gregory Brisson, MD, discussed how peer evaluation among physicians could enhance the patient referral process in a recent NEJM editorial.
The overexpression of mitochondrial superoxide dismutase, commonly found in late-stage tumors, may drive cancer stem cell formation and contribute to the failure of chemotherapy treatment in breast cancer patients.
Scientists co-led by Sui Huang, MD, PhD, found an experimental drug called metarrestin significantly reduced metastasis and cancer progression in mouse models.
David Cella, PhD, Susan Quaggin, MD, John Rogers, PhD, and Catherine Wolley, PhD, have been elected to the National Academy of Medicine, one of the highest honors in the field.
Northwestern University Feinberg School of Medicine received a record $534 million in research funding and awards during the 2018-2019 fiscal year.